Trial Profile
Study of drug resistance virus in Sofosbuvir/Ribavirin combination therapy to genotype 2 chronic hepatitis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2019
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 Jun 2015 New trial record